Park Place Capital’s ResMed RMD Stock Holding History

Park Place Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.3K	Hold	130	–	–	﹤0.01%	596
2026 Q1	$29.2K	Hold	130	–	–	0.01%	435
2025 Q4	$31.3K	Hold	130	–	–	0.01%	399
2025 Q3	$35.6K	Hold	130	–	–	0.01%	377
2025 Q2	$33.3K	Sell	130 -300	-70%	-$71.6K	0.01%	399
2025 Q1	$96.3K	Hold	430	–	–	0.03%	264
2024 Q4	$98.3K	Sell	430 -26	-6%	-$6.26K	0.03%	271
2024 Q3	$111K	Hold	456	–	–	0.03%	274
2024 Q2	$87.3K	Sell	456 -13	-3%	-$2.64K	0.03%	295
2024 Q1	$92.9K	Buy	469 +16	+4%	+$2.93K	0.03%	319
2023 Q4	$77.9K	Buy	453 +13	+3%	+$2K	0.03%	352
2023 Q3	$65.1K	Hold	440	–	–	0.02%	429
2023 Q2	$96.1K	Sell	440 -21	-5%	-$4.68K	0.03%	361
2023 Q1	$101K	Hold	461	–	–	0.03%	350
2022 Q4	$96K	Buy	+461	New	+$101K	0.03%	363

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Park Place Capital's RMD Position: Q2 2026 in Review

Park Place Capital held its ResMed (RMD) position steady in Q2 2026 at 130 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #596.

Park Place Capital first reported a position in RMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $111K in Q3 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Park Place Capital held 130 shares of ResMed worth $25.3K as of Q2 2026.
Park Place Capital left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #596 holding.
Park Place Capital first reported a position in ResMed in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's ResMed position peaked at $111K in Q3 2024.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.